Nilotinib Capsule
Product Images NDC 69097-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 69097-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg-genvi (150mg Genvi)

150mg-genvi (150mg Genvi)
Packaging label for Nilotinib Capsules 150 mg per capsule by Cipla USA Inc. The label includes dosage form as capsules for oral use with warnings to take capsules on an empty stomach and avoid food for at least 2 hours before and 1 hour after dose. Storage instructions and handling information are visible along with the NDC number 69097-031-01 and manufacturer details.*
FDA Label Image

150mg-goa (150mg Goa)

150mg-goa (150mg Goa)
Label for Nilotinib Capsules 150 mg per capsule, an oral human prescription drug. The label shows the product name prominently with dosage strength, includes directions for prescription use, and states that the capsules should be taken with food. The labeler is Cipla USA Inc. Packaging information includes 112 capsules in bottles containing 28 capsules each, with safety and usage instructions.*
FDA Label Image

200mg-genvi (200mg Genvi)

200mg-genvi (200mg Genvi)
Packaging label for Nilotinib Capsules, 200 mg per capsule, oral dosage form by Cipla USA Inc. The label includes directions to take capsules on an empty stomach with water or food, with warnings and storage instructions. The label displays the NDC number 69097-032-41 and indicates the product is prescription only, containing 12 capsules per package.*
FDA Label Image

200mg-goa (200mg Goa)

200mg-goa (200mg Goa)
Nilotinib Capsules 200 mg per capsule oral capsules packaging label from Cipla USA Inc. The label includes dosing strength, pharmacist instructions to dispense with medication guide, and warnings to take on an empty stomach with specific timing around meals. The label design features a white background with a prominent magenta banner displaying the strength, and the Cipla logo in blue.*
FDA Label Image

50mg-genvi (50mg Genvi)

50mg-genvi (50mg Genvi)
Nilotinib 50 mg capsules medication label from Cipla USA Inc. The label specifies 120 capsules per container and advises dispensing with a medication guide. It includes dosing instructions, storage conditions, manufacturer and labeler information, and a barcode for product identification.*
FDA Label Image

50mg-goa (50mg Goa)

50mg-goa (50mg Goa)
Nilotinib 50 mg capsules label from Cipla USA Inc. The label specifies dosage and storage instructions, including taking capsules on an empty stomach and storing between 15°C and 30°C. The package contains 120 capsules and includes a national drug code (NDC) and barcode. The label also cautions to dispense with a medication guide.*
FDA Label Image

Fig-1 (Fig 1)

Fig-1 (Fig 1)
A Kaplan-Meier survival curve depicting treatment-free survival (TFR) percentage over time in weeks for Nilotinib. The graph includes a solid treatment survival line with dashed confidence interval boundaries. The x-axis shows duration in weeks, while the y-axis represents treatment-free survival percentage, illustrating trends in patient survival and censored observations over approximately 140 weeks.*
FDA Label Image

Fig-2 (Fig 2)

Fig-2 (Fig 2)
A survival curve graph depicting treatment-free survival percentage over time in weeks since treatment-free remission (TFR). The x-axis represents time since TFR in weeks, ranging from 0 to 144, and the y-axis shows treatment-free survival percentage from 0% to 100%. The graph includes a solid survival curve with confidence intervals, censored observations marked, and a summary table of patients at risk, events, and censored data below the x-axis.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient Nilotinib, showing its molecular composition and arrangement of atoms as connected rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.